Addex Therapeutics
Yahoo Finance • 12 days ago
Addex Therapeutics GAAP EPS of -CHF 0.02, income of CHF 0.04M
* Addex Therapeutics press release [https://seekingalpha.com/pr/20248213-addex-therapeutics-reports-2025-half-year-and-second-quarter-financial-results-and-provides] (NASDAQ:ADXN [https://seekingalpha.com/symbol/ADXN]): Q2 GAAP EPS of -C... Full story
Yahoo Finance • 13 days ago
Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update
Cash position of CHF 2.3 million at end of H1 2025GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to phase 2 mGlu2 PAM asset, ADX71149Indivior advanced GABAB PAM substance use d... Full story
Yahoo Finance • 17 days ago
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
Geneva, Switzerland, September 26, 2025- Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today an... Full story
Yahoo Finance • 20 days ago
Addex Appoints Bank of New York Mellon as Depositary Bank
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 23, 2025-Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric... Full story
Yahoo Finance • 3 months ago
Stalicla secures CHF 2M investment led by Addex for neuropsychiatric drug development
Addex Therapeutics (NASDAQ:ADXN [https://seekingalpha.com/symbol/ADXN]) has led a CHF 2 million investment [https://seekingalpha.com/pr/20151253-addex-leads-chf-2-million-investment-in-stalicla-to-advance-precision-medicine-in] in Stalicla... Full story
Yahoo Finance • 4 months ago
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress
Addex Therapeutics (ADXN), a small-cap biotech company with a market capitalization of $7 million, reported its Q1 2025 financial performance, revealing a decrease in income compared to the previous year but showcasing promising advancemen... Full story
Yahoo Finance • 4 months ago
Addex Therapeutics GAAP EPS of -CHF 0.01, income of CHF 0.07M
* Addex Therapeutics press release [https://seekingalpha.com/pr/20140147-addex-therapeutics-to-release-q1-2025-financial-results-and-host-conference-call-on-june-19] (NASDAQ:ADXN [https://seekingalpha.com/symbol/ADXN]): Q1 GAAP EPS of -C... Full story
Yahoo Finance • last year
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Financials, Technology and Telecoms sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.02% to hit a new all time hig... Full story
Yahoo Finance • last year
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder Tuesday, Addex Therapeutics Ltd (NASDAQ:ADXN) stock is trading higher with a session volume of 3.79 million versus the average volume o... Full story
Yahoo Finance • 3 years ago
15 Top Performing European Stocks So Far in 2023
In this article, we will take a look at the 15 top performing European stocks so far in 2023. To see more such companies, go directly to 5 Top Performing European Stocks So Far in 2023. The Bank of England on March 23 raised its benchmark... Full story
